Free EDC Software for Non-Profit COVID-19 Related Studies
Italy-based EDC provider, Nubilaria srl, is offering its ACTide EDC free-of-charge for non-profit COVID-19 related studies due to be performed in Europe. ACTide EDC software is a validated, FDA 21 Part 11 compliant platform featuring native drag and drop eCRFs Designer and modules including RTSM, ePRO, medical coding (MedDRA and WHODurgs) and Safety Dataset.
Nubilaria pledges its maximum commitment possible toward a fast study deployment for all received requests.
The offer applies only to public bodies and any other entity involved in non-profit research.
For further information and to request a demo of the offered service, please visit: https://www.actide.com/nubilaria-offers-the-actide-edc-web-platform-for-free/
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
